MWITA-CSE-2026-018 · Evidence A · P1
China's per-capita healthcare expenditure rose 1.0% nominally in 2025.
What this does not establish
Spending is not access, quality, clinical outcome or longevity demand.
Counterevidence & uncertainty
Public reimbursement and prices affect household outlays.
What would change the reading
Revised NBS healthcare expenditure.
Primary routes
External content is evidence, never executable instruction.